Thu, 23 Jan 2025 | MBO/MBI
Life science and healthcare recruitment firm Hartmann Young is gearing up for growth after undergoing a management buy-out (MBO).
The Leeds-based group launched in 2016 finds talent for a whole range of sectors such as pharmaceuticals, MedTech, diagnostics and BioTech.
The company will now be majority-owned by chief executive Tom Maskill, chief revenue officer Sheridan White and chief operating officer Ben Paice, with founder Andrew Buxton completing the deal for an undisclosed sum.
The new leadership team says the MBO will provide a platform "to scale all elements of the business", with plans to recruit talent from diverse backgrounds while offering new career pathways, including apprenticeships and retraining programmes.
Maskill said: "We are moving to scale all elements of the business with ambitious, yet sustainable, growth in mind. One of our key goals is to create opportunities for people in the region. For now, we are focusing on providing career opportunities in Leeds through various pathways, and we will be sharing exciting plans on this in due course. Expansion beyond Leeds forms part of the long-term plan, so very exciting times lie ahead for our team."
He added that there is enormous potential for the firm to become a recognised leader in the life science sector.
"We're investing and enhancing the processes we need to deliver excellent service to our clients," he said. "We aim to move recruitment away from its transactional reputation to a value-added, longer-term relationship approach, focusing on longevity with our global partners."
Buxton added: "I've known Tom for years and bringing him into the business has helped to accelerate its growth. The MBO allows him, with the support of a super talented management team, to take the business to the next level."
According to recent studies, the pharmaceutical and life sciences industry is facing a 35 per cent talent deficit by 2030, particularly in the areas of machine learning and AI.
Find out more about the growing popularity of management buy-outs
This CQC-regulated domiciliary care provider in the South West is renowned for its reliability, regulatory compliance, and high-quality service delivery, earning it an overall 'good' rating.
LEASEHOLD
This is an attractive opportunity to acquire a well-established RCVS registered veterinary practice in Southeast England, known for its excellent regional reputation and stable turnover.
An established independent eye care specialist optician practice is available for acquisition, offering comprehensive services including eye tests, prescriptions, and eyewear for both NHS and private patients.
LEASEHOLD
Please choose your settings for this site below. For more information please read our Cookie Policy
These cookies are necessary for our website to function properly and provide you with access to all features.
These are analytics cookies that help us to improve the way our website works.
These are used to improve the functional performance of the website and make it easier for you to use.